159 related articles for article (PubMed ID: 27072961)
1. Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.
Bao ZQ; Zhang CC; Xiao YZ; Zhou JS; Tao YS; Chai DM
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):193-199. PubMed ID: 27072961
[TBL] [Abstract][Full Text] [Related]
2. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of N-cadherin and β-catenin protein in osteosarcoma].
Yang JZ; Zhang XH; Liu JR; Ding Y; Gao F; Wang Y
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):586-9. PubMed ID: 21122409
[TBL] [Abstract][Full Text] [Related]
5. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].
Li W; Liu X; Zhang G; Zhang L
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536
[TBL] [Abstract][Full Text] [Related]
6. [Expression of transcription factor SOX4 and its clinical significance in female lung cancer patients in Xuanwei area, Yunnan Province].
Zhou YC; Wang XC; Chen Y; Zhang LJ; Liu X; Yao Q; Chen XQ; Zhao GQ; Huang YC
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):202-6. PubMed ID: 23880001
[TBL] [Abstract][Full Text] [Related]
7. miR‑188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma.
Pan L; Meng L; Liang F; Cao L
Mol Med Rep; 2018 Jul; 18(1):441-446. PubMed ID: 29749512
[TBL] [Abstract][Full Text] [Related]
8. DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo.
Chen D; Hu C; Wen G; Yang Q; Zhang C; Yang H
Calcif Tissue Int; 2018 Jan; 102(1):117-127. PubMed ID: 29038881
[TBL] [Abstract][Full Text] [Related]
9. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
10. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
[TBL] [Abstract][Full Text] [Related]
11. Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma.
Kong G; Liu Z; Wu K; Zhang Y; Deng Z; Feng W; Chen S; Wang H
Tumour Biol; 2015 Sep; 36(10):7735-41. PubMed ID: 25936343
[TBL] [Abstract][Full Text] [Related]
12. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
13. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
14. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
Liu Y; Abulimiti N; Wang C
Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
[TBL] [Abstract][Full Text] [Related]
15. FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas.
Kim KM; Hussein UK; Park SH; Kang MA; Moon YJ; Zhang Z; Song Y; Park HS; Bae JS; Park BH; Ha SH; Moon WS; Kim JR; Jang KY
J Exp Clin Cancer Res; 2019 Jun; 38(1):267. PubMed ID: 31215499
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.
Xie Y; Huang J; Wu M; Zhou Y
J Cancer Res Ther; 2018; 14(4):892-895. PubMed ID: 29970672
[TBL] [Abstract][Full Text] [Related]
18. High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.
Hu F; Shang XF; Wang W; Jiang W; Fang C; Tan D; Zhou HC
Int J Exp Pathol; 2016 Feb; 97(1):86-92. PubMed ID: 27028305
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated SOX4 expression suppresses cell proliferation, metastasis and induces apoptosis in Xuanwei female lung cancer patients.
Zhou Y; Wang X; Huang Y; Chen Y; Zhao G; Yao Q; Jin C; Huang Y; Liu X; Li G
J Cell Biochem; 2015 Jun; 116(6):1007-18. PubMed ID: 25565486
[TBL] [Abstract][Full Text] [Related]
20. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
